Dec 5, 2025, 09:12 AM by

Company’s third Human Factors Formative Study shows that 95% of participants prefer the Vaxess microarray patch to traditional injection devices

Dec 4, 2025, 08:38 AM by

PrecisionLife has announced new findings from the most detailed genetic analysis of myalgic encephalomyelitis ever conducted offering potential for faster and lower-risk routes to developing targeted treatments.

Dec 4, 2025, 08:38 AM by

4D Path, a company dedicated to personalizing cancer care through a novel, physics-inspired approach to predicting tumor response to therapy, today announced that the company’s Q-Plasia OncoReader (QPOR™) platform has successfully predicted treatment response in patients with early-stage triple-negative breast cancer (TNBC) using digitized baseline biopsy images. Analysis conducted within the Translational Breast Cancer Research Consortium (TBCRC) 030 clinical trial represents the first demonstration of a statistical physics and tumor biology-based computational biomarker predicting post-treatment outcomes from pre-treatment tissue alone, without any clinical or molecular inputs.

Dec 4, 2025, 01:01 AM by User Not Found

Bio-IT World | Since artificial intelligence (AI) made its way into the medical field, foundation models—machine learning systems that are trained on broad data and adaptable to a wide range of downstream tasks—have become a focus. These foundation models are used to perform various medical tasks with minimal amounts of data. Of course, this means that these models require robust training, which poses a challenge for researchers.

Dec 3, 2025, 09:21 AM by

Compliance with independent security standards comes as Proscia accelerates digital pathology deployments at scale

Dec 3, 2025, 01:01 AM by User Not Found

Bio-IT World | As genetic testing becomes a routine part of modern medicine, researchers are grappling with an unintended consequence: a flood of never-before-seen genetic variants whose clinical significance is unknown. These variants of uncertain significance (VUS), now number in the tens of thousands, outpace the capacity of traditional scientific methods to determine whether they contribute to disease.

Dec 2, 2025, 01:01 AM by User Not Found

Bio-IT World | How depression gets treated in the next decade is poised for significant change thanks to encouraging developments in the use of psychedelics and dissociative compounds like ketamine to alleviate symptoms of the mood disorder. Scientific interest in psychedelic-based therapies has skyrocketed in recent years, driven by promising clinical trial outcomes, a flood of financial investment, and the urgent need for new treatments to counter a growing mental health crisis

Dec 1, 2025, 08:56 AM by

Nov 26, 2025, 08:05 AM by

Nov 25, 2025, 01:01 AM by User Not Found

Bio-IT World | Azalea Therapeutics will advance their Enveloped Delivery Vehicle (EDV) technology; Gate Biosciences will advance inflammatory and neurological disease treatments through the convenience of a pill; and more.

Nov 24, 2025, 07:58 AM by

Biocair, an established global leader in life science logistics, today announced the relocation of its Paris facility to a new, substantially larger premises strategically positioned within the Paris-Charles de Gaulle airport cargo zone.

Nov 24, 2025, 01:01 AM by User Not Found

Bio-IT World | Eli Lilly plans to open a new lab in Philadelphia; QIAGEN enters into a definitive agreement to fully acquire Parse Biosciences; Novartis announced plans to expand a flagship hub in North Carolina; and more.

Nov 21, 2025, 08:11 AM by

Nov 21, 2025, 07:58 AM by User Not Found

Bio-IT World | Ginkgo Datapoints has launched V-Ref293, a novel engineered cell line designated specifically as the reference standard for virtual cell research. Along with the cell line, the group is launching the Virtual Cell Pharmacology Initiative (VCPI), the first project under The Virtual Cell bio-AI community platform from Ginkgo Datapoints.

Nov 20, 2025, 08:22 AM by

Nov 19, 2025, 07:52 AM by

Nanopath, a point-of-care diagnostics company enabling high-quality molecular testing in minutes, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation for the company's novel assay for the rapid detection of infection in patients with suspected, or at risk of, complicated urinary tract infections (UTIs).

Nov 19, 2025, 07:52 AM by

Accelerating medical device validation with digital solutions, risk-based methodology, and proven regulatory expertise.

Nov 19, 2025, 01:00 AM by User Not Found

Bio-IT World | Progress on women’s health, which was only truly recognized at the federal level when the Food and Drug Administration (FDA) asked for the inclusion of women in clinical trials in 1993, encountered a large obstacle earlier this year when the White House cut off a major funding initiative established by previous administrations intended to right the harms from decades of largely failing to include women in medical research. The move marks a succession of blind spot moments in the history of human research that have had damaging consequences for women.

Nov 18, 2025, 08:24 AM by

Zymo Research, a global leader in epigenetics and next-generation sequencing (NGS), has entered a strategic partnership with biomodal, an omics-based life sciences technology and analytics company. As part of biomodal’s certified provider network, Zymo Research’s NGS Services division is now authorized to deliver services using biomodal’s duet multiomics solution evoC and duet multiomics solution +modC, enabling researchers to access comprehensive genetic and epigenetic insights from a single DNA sample.

Nov 18, 2025, 01:01 AM by User Not Found

Bio-IT World | Last week, The Garvan Institute of Medical Research in Australia, the University of Tokyo in Japan, and 10x Genomics announced an initiative to create a comprehensive pan-cancer spatial atlas. The Asia-Pacific Spatial Translational Research Alliance (ASTRA), a consortium that fosters collaboration in spatial research across the Asia-Pacific region, will use 10x Genomics’ Xenium spatial platform to map how cancer and immune cells communicate across 2,000 tumor samples.